Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for CSBTF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
December 31, 2013 -6.297M
September 30, 2013 -21.54M
June 30, 2013 -12.98M
March 31, 2013 -4.856M
December 31, 2012 0.5768M
September 30, 2012 5.010M
June 30, 2012 10.74M
March 31, 2012 -15.26M
December 31, 2011 -18.96M
September 30, 2011 -16.83M
June 30, 2011 -11.39M
March 31, 2011 -5.462M
December 31, 2010 0.2071M
September 30, 2010 6.742M
June 30, 2010 11.44M
March 31, 2010 -2.841M
December 31, 2009 0.5765M
September 30, 2009 1.356M
June 30, 2009 6.079M
March 31, 2009 10.60M
December 31, 2008 22.01M
September 30, 2008 19.28M
June 30, 2008 31.24M
Date Value
March 31, 2008 36.86M
December 31, 2007 40.63M
September 30, 2007 47.68M
June 30, 2007 26.23M
March 31, 2007 34.80M
December 31, 2006 37.60M
September 30, 2006 42.43M
June 30, 2006 49.35M
March 31, 2006 51.87M
December 31, 2005
September 30, 2005
June 30, 2005
March 31, 2005
December 31, 2004 71.13M
September 30, 2004 69.90M
June 30, 2004 74.89M
March 31, 2004 78.82M
December 31, 2003 58.95M
September 30, 2003 55.65M
June 30, 2003 57.51M
March 31, 2003 62.36M
December 31, 2002
September 30, 2002 43.17M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Molecular Partners AG 72.58M
Basilea Pharmaceutica AG --
Santhera Pharmaceuticals Holding AG --
BeOne Medicines Ltd. 5.174B
AC Immune SA 43.60M